Daily Stock List
Poynt Corp. (PNYTF)
We are highlighting Poynt Corp. (PNYTF) as "One to Watch" here at the QualityStocks Daily Newsletter.
Poynt Corp. is a mobile local search and advertising company. The company’s flagship product is Poynt Local Search. This is an all-in-one local search tool for Blackberry© smartphones, Blackberry Playbook™ Tablet, Android, iPhone, Nokia QT, and Windows Phone 7 devices. Poynt is a convenient and timesaving GPS-enabled mobile local search and advertising platform.
Poynt entered the mobile ad publishing space to deliver targeted advertisements and offers from retailers desiring to capture the consumer at the purchase decision point. Poynt has their corporate headquarters in Calgary, Alberta. The company’s shares trade on the TSX Venture Exchange under the symbol PYN and on the OTCQX under the symbol PNYTF.
Poynt Local Search is currently available for the above-mentioned devices in Canada, the United States, the United Kingdom, Italy, France, Spain, Germany, India, and Australia. The Poynt app was launched in North America for the BlackBerry in June of 2008. Millions of people use the company’s platform when looking for retailers, restaurants, events, as well as nearby offers.
By way of the Poynt Local Search Platform, the company delivers a unified, intuitive, and actionable experience to consumers on their mobile devices. Poynt provides contextual and relevant advertising to users performing local queries. The basis of the company’s revenue model is on user queries, page views, advertising, and transactions within the platform.
Poynt Local Search is a user-friendly, all-in-one app. It has a Business Search feature – a mobile version of the yellowpages. It also has Movie Search, Restaurant Search, Events Search, and People Search features. Furthermore, it has a Gas Search feature (U.S. and U.K. users) for finding the least expensive fuel in a region. In addition, along with the Offers feature, Poynt Local Search comes with a fully integrated Weather Display and long-term forecasts, and Maps and turn-by-turn Directions to any search listing.
In February, Poynt announced the structuring of their first Asian operating entity, Poynt Asia (Hong Kong) Ltd. (Poynt HK) and the formation of a Joint Venture (China Youth Poynt Ltd.) between Poynt HK and China Youth League’s affiliated entity, China Youth Goyor Technology (Beijing) Co, Ltd. (China Youth Goyor).
China Youth Goyor, as an initial objective of the China JV, will focus on obtaining the Chinese Ministry licenses required for conducting the business of China Youth Poynt, securing data service agreements and preload agreements in China with major telecom companies, and facilitating consumer usage of the Poynt mobile platform in China (the China Youth Poynt Platform).
We have Poynt Corp. (PNYTF) locked on our radar screens as "One to Watch" here at the QualityStocks Daily Newsletter.
Poynt Corp. (PNYTF) closed on Wednesday at $0.14, even with yesterday’s close. The average volume for the last 60 days is 24,189. The 52-week low/high is $0.08/$0.24.
TheraBiogen, Inc. (TRAB)
SmallCapVoice reported recently on TheraBiogen, Inc. (TRAB), Greenbackers, FeedBlitz, PennyStockPromo, SteroidStocks, Breakthroughstocks Team, OTC Advisors, ShamrockStocks did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
TheraBiogen, Inc. is a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The manufacture of these products is from natural, homeopathic ingredients and they contain no zinc. The Company's focus is to sell their products in North America and globally. Founded in 2000, TheraBiogen has their corporate headquarters in Manalapan, New Jersey. The Company lists on the OTC Bulletin Board.
The Company's Thera Max® Cold and Flu is an all-natural, non-addictive, over the counter cold and flu relief agent. It aids in relief to cold and flu sufferers. The product currently sells in more than 12,000 locations. The product is a homeopathic product of ingredients pre- approved on the HPUS website. Independent studies suggest the product aids in the temporary relief of common cold and flu ailments such as sneezing, runny nose, itch-watery eyes, nasal congestion and sinus pressure and can aid in the prevention if used correctly.
Thera Max® Allergy Relief is a remedy for seasonal allergy symptoms. The new formulation aids in the relief of these symptoms such as sneezing, wheezing, runny nose, watery red eyes. TheraBiogen has a pipeline of products under development, including sore throat and migraine remedies.
Thera Max® is available for purchase in a variety of locations. These include Rite-Aid, Food Lion, and Hannaford Supermarkets, Discount Drug Marts and Big Y Supermarkets as well as two of the three largest drug retailers.
Last week, TheraBiogen announced the benefits their Thera Max® Cold and Flu brand is receiving through an ongoing Social Media campaign. The Company is taking their new homeopathic product, Thera Max® Cold and Flu into the social media arena in a very aggressive fashion. The campaign launched on a billboard in Times Square, with interview testimonials posted on YouTube. Moreover, CEO Kelly Hickel started a radio media tour that has attracted editorial interest. TheraBiogen believes that several other opportunities will develop from these efforts.
TheraBiogen, Inc. (TRAB) closed on Wednesday at $0.03, down 7.01%, on 66,000 volume with 4 trades. The average volume for the last 60 days is 162,262. The 52-week low/high is $0.03/$1.45.
Adino Energy Corp. (ADNY)
FeedBlitz, OTCPicks, M2 Communications, and MicrocapVoice reported previously on Adino Energy Corp. (ADNY), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Trading on the OTC Bulletin Board, Adino Energy Corp. is an emerging oil & gas exploration and production company. They focus on mature oilfield assets with significant redevelopment, work-over, and enhanced oil recovery (EOR) potential. They also own a fuel terminal operation in the Houston, Texas area. Adino Energy has their headquarters in Houston.
The Company, via their subsidiary, Intercontinental Fuels, LLC, operates the fuel storage terminal in Houston. Their terminal distributes petroleum based products and bio diesel to local wholesale and retail fuel distributors. The terminal has 160,000 barrels of capacity. A three-bay loading rack situated on 10 acres next to Houston's IAH airport, services it. Intercontinental Fuels offers storage, terminalling and blending services, as well as ultra-low sulphur and biodiesel.
The Company's Adino Exploration is a bonded Texas Oil and Gas Operator with leases in Coleman and Runnels counties. The Company launched operations in July of 2010 with two leases producing less than four bopd of crude oil. The James Leonard project is 94.6 acres in southwest Coleman County, Texas. It has shallow prospects with potentially quality economics. Adino has a 100 percent Working Interest (WI) and an 86.5 percent Net Revenue Interest (NRI).
Their Felix Brandt project is a mature lease with 12 wellbores. The Company has a 100 percent WI and a 76.5 percent NRI. Their Coats project consists of 320 acres in Runnels County, Texas. There exist a number of potentially productive zones (Gardner, Morris, Gray, and Ellenburger). Adino has a 100 percent WI, and a 77.0 percent NRI.
In November 2011, Adino Energy announced the acquisition of all unencumbered assets owned by two limited partnerships managed by Ashton Oilfield Services, LLC. On October 12, 2011, Adino Energy signed a Letter Of Intent (LOI) to purchase all of the assets of Ashton. Under the letter of intent, Adino will purchase the assets for $6,000,000 of preferred stock with an effective conversion price of $0.15 per share of common stock. The LOI allows for multiple closings as titles are cleared.
Adino Energy Corp. (ADNY) closed on Wednesday at $0.01, down 37.50%, on 825,665 volume with 28 trades. The average volume for the last 60 days is 195,260. The 52-week low/high is $0.01/$0.05.
Manhattan Scientifics Inc. (MHTX)
Hawk Associates reported recently on Manhattan Scientifics Inc. (MHTX), FeedBlitz and StockHotTips did previously, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Manhattan Scientifics Inc. focuses on technology transfer and commercialization of disruptive technologies in the nano medicine space. They are currently developing commercial medical prosthetics applications for their ultra fine grain metals. The Company plans to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, which is a unit of the Company. Manhattan Scientifics has offices in New Mexico, New York and Montreal.
The Company's business model capitalizes on inventions and technology from which profits are created via licensing. They are a technology developer that nurtures financially promising technologies with potential worldwide commercial applications. Manhattan Scientifics has enjoyed a "special informal relationship" and a lengthy successful history in tech-transfer from the Los Alamos National Laboratory (LANL) and the Sandia National Laboratory (SNL).
Concerning Advanced Materials (Nano Titanium), Manhattan Scientifics' nanostructured metal technology is based on more than 16 years of highly focused research and development. The Company has developed unique processing methodology for producing nanostructures in a broad spectrum of ductile metals and alloy. They are now commercializing this new and innovative technology.
Concerning Nanomedicine, Manhattan Scientifics and Senior Scientific announced that they have begun cooperative work to commercialize Senior Scientific's nano medicine cancer detection technology. Manhattan Scientifics acquired the exclusive commercial rights (manufacturing and marketing) to Edward R. Flynn's (President and CEO of Senior Scientific) patents and IP in the emerging field of nano medicine. Specifically this is Dr. Flynn's work in biomagnetic detection of cancer and other diseases through magnetic field sensors.
In February, Manhattan Scientifics announced that The National Foundation for Cancer Research awarded a grant to Dr. Robert C. Bast, Jr. of The University of Texas MD Anderson Cancer Center to work with Senior Scientific to apply Senior Scientifics' technology to the early detection of ovarian cancer. Senior Scientific has pioneered a novel technology using special magnetic sensors and magnetic nanoparticles for a highly sensitive and very specific approach to cancer detection.
The new Ovarian Cancer grant triggers collaboration between Drs. Bast, Flynn and a team led by Richard S. Larson, MD, PhD, Vice Chancellor UNM Health Sciences Center in New Mexico. The new grant, entitled "SQUID Imaging for Detection of Early Stage Ovarian Cancer," will augment Dr. Bast's ongoing program at The University of Texas MD Anderson Cancer Center with this emerging technology.
Manhattan Scientifics Inc. (MHTX) closed on Wednesday at $0.06, down 2.52%, on 28,200 volume with 8 trades. The average volume for the last 60 days is 204,999. The 52-week low/high is $0.03/$0.10.
Northwest Biotherapeutics, Inc. (NWBO)
AllPennyStocks, SmallCapVoice, and The Street reported earlier on Northwest Biotherapeutics, Inc. (NWBO), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Northwest Biotherapeutics is a biotechnology company that lists on the OTC Bulletin Board. The Company focuses on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies. They have a broad platform technology for dendritic cell-based vaccines. Northwest Biotherapeutics has their headquarters in Bethesda, Maryland.
The Company's lead clinical trial is a 240-patient Phase II trial in newly diagnosed Glioblastoma multiforme (GBM). This is the most aggressive and lethal brain cancer. In the earlier Phase I/II clinical trials for GBM brain cancer, patients who received DCVax® showed a median survival of three years compared with median survival of 14.6 months for patients who received standard of care (surgery, radiation and chemotherapy). Patients who received DCVax® also experienced a substantially longer time to tumor recurrence: a median of two years, compared with 6.9 months in patients who received standard of care. DCVax® was well tolerated, with no toxic side effects.
Northwest Biotherapeutics also previously received clearance from the Food and Drug Administration (FDA) for a 612-patient Phase III trial in prostate cancer, and clearance from the FDA for Phase I trials in multiple other cancers. The Company has also conducted a Phase I/II trial with DCVax® for recurrent metastatic ovarian cancer.
DCVax® is a platform technology that can be applied to multiple cancers. It combines a patient's own dendritic cells (DC) with cancer related proteins, or antigens, with the aim of inducing immune responses against a patient's cancer cells.
Last month, Northwest Biotherapeutics announced that they now have 30 clinical trial sites open and recruiting across the U.S. in their ongoing Phase 2 clinical trial of DCVax®-L immune therapy for GBM. The Company reached this milestone ahead of schedule. They had projected to reach it by the end of Q1, 2012. They also met or exceeded their projections in the three preceding quarters (Q2, Q3 and Q4 of 2011), as previously announced.
The Company plans to continue adding clinical trial sites. They expect to have a minimum of 40 sites open and enrolling by the end of Q2, 2012. They will also continue pursuing their programs in Europe.
Northwest Biotherapeutics, Inc. (NWBO) closed on Wednesday at $0.31, down 2.36%, on 291,344 volume with 47 trades. The average volume for the last 60 days is 188,093. The 52-week low/high is $0.26/$0.89.
Turbine Truck Engines, Inc. (TTEG)
SmallCapVoice, Pumps and Dumps, Otc Mega Stock Picks, Free Investment Report, and The Ox of Wallstreet reported earlier on Turbine Truck Engines, Inc. (TTEG), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Turbine Truck Engines, Inc. is a technology company focusing on the development, manufacture, and distribution of their new energy efficient and environmentally friendly products. Turbine Truck Engines is the exclusive agent for Hydrogen Union Energy Co. Ltd.'s (HUE) hydrogen generation technology throughout all of North America. Turbine Truck Engines is aggressively pursing expansion opportunities through partnerships, joint ventures, and acquisitions. The Company's shares trade on the OTC Bulletin Board. Turbine Truck Engines is based in Paisley, Florida.
HUE has developed a breakthrough technology for generating "on-demand" hydrogen employing a proprietary chemical catalyst and a unique low temperature pyrolytic reaction. HUE's Hydrogen Generator technology converts common methanol into clean-burning hydrogen gas for immediate on-site use. Hydrogen (H2) is an ideal fuel for combustion. It burns easily and efficiently at very high temperatures and emits pure water vapor (H2O) as its only by-product.
Turbine Truck Engines owns an exclusive worldwide license for the manufacturing and marketing of a highly innovative, low emissions turbine-based truck engine. It is known as the Detonation Cycle Gas Turbine (DCGT) engine. The Company believes their patented cyclic detonation technology, when completed, could revolutionize the heavy-duty truck engine market.
Last month, Turbine Truck Engines announced that as part of the ongoing evolution of completing the joint venture between Turbine Truck Engines (a Nevada corporation) and Energy Technology Services Co., Ltd. (ETS) (a Taiwan corporation) the filing of documents to form a new joint venture company have been approved by both companies. The companies have named the new entity Global Hydrogen Energy Co., Ltd. (a Taiwan corporation) with company headquarters located in Taipei, Taiwan. Turbine Truck Engines, as previously announced, is entering into a joint venture with ETS, parent company of HUE to jointly develop and market Hydrogen Energy business "worldwide for both commercial and industrial applications".
Recently, Turbine Truck Engines announced that as part of the ongoing evolution of completing the joint venture their CEO, Michael Rouse, has been appointed as a member of the Board of Directors for ETS.
Turbine Truck Engines, Inc. (TTEG) closed on Wednesday at $0.19, up 2.78%, on 22,788 volume with 4 trades. The average volume for the last 60 days is 116,552. The 52-week low/high is $0.02/$0.27.
Titan Trading Analytics Inc. (TITAF)
We are highlighting Titan Trading Analytics Inc. (TITAF), here at the QualityStocks Daily Newsletter.
Titan Trading Analytics Inc. is a premier provider of behavioral trading research. Trade signals undergo distribution through a powerful financial analysis and electronic trading software platform. This platform captures and analyzes real-time market tick data and social media sentiment and identifies trade opportunities based on matching real-time and historical patterns, identified by Titan's Trade Signal Engine™ (TRE). Titan lists on the TSX Venture Exchange (TTA.V) and on the OTC Bulletin Board under the symbol TITAF.
The Company's internally developed products and services are at the forefront of the high growth global investment management and automated trading industry. Titan's flagship product is TickAnalyst™. It delivers trading signals to proprietary trading firms and hedge funds through an innovative browser-based interface.
TickAnalyst monitors real-time data and simultaneously sifts through years of historical ticks to stream behavioral trading signals right to a user's desktop. Hedge funds or Proprietary firms with small IT staff, Prime Brokers looking to offer non-HFT strategies, and Retail Brokers looking for an institutional strength pattern recognition application for active traders use TickAnalyst™.
In January, Penton's Registered Rep, a source for financial advisors and wealth managers, announced two new offerings on www.registeredrep.com to help advisors make investment decisions using social behavioral research. The tools were exclusively developed by Titan Trading Analytics. This is the first time that Registered Rep and Titan have worked together to create a financial information and investment tool.
The Social Behavioral Research Dashboard is a series of Finance 2.0 research reports that combine web analytics, social media sentiment and quantitative research on all major industry sectors of the S&P 500. A complimentary report is available along with additional industry reports. The aforementioned TickAnalyst is another new offering that streams signals mined from a massive financial database that include 10 years of price, volume and volatility data along with real-time social media stock data, which quantify and qualify stocks using a series of 14 proprietary algorithms.
Titan Trading Analytics Inc. (TITAF) closed on Wednesday at $0.07, even with yesterday’s close. The average volume for the last 60 days is 5,819. The 52-week low/high is $0.04/$0.17.
Bioniche Life Sciences Inc. (BNC.TO)
We are reporting on Bioniche Life Sciences Inc. (BNC.TO) today, here at the QualityStocks Daily Newsletter.
Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company that lists on the Toronto Stock Exchange. They focus on the discovery, development, manufacturing, and marketing of proprietary and innovative products for human and animal health markets globally. The fully-integrated company has three operating divisions. These are Human Health, Animal Health, and Food Safety. Bioniche Life Sciences has their headquarters in Belleville, Ontario.
The Company's primary goal is to develop and commercialize products that advance human or animal health and increase shareholder value. Bioniche Life Sciences has been named one of the Top 50 Best Small and Medium-Sized Employers in Canada for 2011. The Company employs more than 200 skilled personnel and they have research, manufacturing, and marketing/sales facilities in Belleville; Montreal, Quebec; Athens, Georgia; Pullman, Washington; and Armidale and Sydney, Australia. Key areas of strategic focus for the Company include effective therapies for bladder cancer and potentially other cancers; a cattle vaccine to help prevent E. coli O157:H7 infection, and technologies to improve reproduction and potentially replace the use of antibiotics in livestock.
Bioniche Life Sciences' Animal Health and Food Safety Vaccine Manufacturing Centre (VMC) in Belleville, Ontario has been undergoing validation and commissioning to meet North American production standards for the past several months. This process has proceeded according to plan. Production scale-up is now beginning. This involves moving the Company's Econiche™ cattle vaccine against E. coli O157 from the production laboratory into the VMC fermentors. The expectation is that a first commercial batch of Econiche™ will be made in the VMC by mid-2012.
In February, Bioniche Life Sciences announced financial results for the second quarter of their 2012 fiscal year ended December 31, 2011. Consolidated revenues for the quarter were $8.1 million, compared to $11.0 million in the same period in Fiscal 2011. On a year-to-date basis, consolidated revenues were $14.9 million compared to $18.5 million for the first six months in Fiscal 2011. Certain non-recurring licensing revenue was included for the Fiscal 2011 reporting period.
Revenues associated with Animal Health product sales increased in the quarter by $1.3 million compared to the same quarter in Fiscal 2011 (revenues increased from $6.1 million to $7.4 million). The Company had gross margins of 52.4 percent in the period versus 51.4 percent in Fiscal 2011. The basic and fully-diluted net loss for the three-month period ending December 31, 2011 was $(0.04) per share, compared to $(0.03) in the same period of Fiscal 2011. The year-to-date basic and fully diluted net loss is $(0.08) per share, compared to $(0.06) in the same period last year.
Bioniche Life Sciences Inc. (BNC.TO) closed on Wednesday at $0.75, up 15.38%, on 180,846 volume. The 52-week low/high is $0.47/$1.41.
TiVUS, Inc. (TIVU)
The QualityStocks Daily Newsletter would like to spotlight TiVUS, Inc. (TIVU). Today, TiVUS, Inc. closed trading at $0.0005, up 25.00%, on 15,520,254 volume with 22 trades. The stock’s average daily volume over the past 60-day daily average volume is 21,385,006 with a 52-week low/high of $0.0001/$0.036.
TiVUS, Inc. (TIVU) is a cutting edge provider of information, content distribution, media management and secure communications to the hospitality industry. The company's state of the art digital technology platform and Internet Protocol (IP) infrastructure presents hotels with a valuable opportunity to generate new revenue while enhancing guests' experiences by providing content that is more relevant to their unique interests.
The company's integrated platform stands far beyond the competition, offering unparalleled guest services such as messaging, folio review, express check outs, energy management and other personalized services while providing the traditional services of Free to Guest (FTG) programming, Video-On-Demand programming, a highly secured high speed internet service and many other interactive services such as gaming.
By combining TV and the web world through unparalleled IPTV/HDTV service, hotels are able to generate additional income through commercial spots, advertisements of local tourist services, hotel promotions and more. Features of the platform includes remote administration, support for more than twenty languages, easy installation and a comprehensive hotel services menu capable of providing detailed information about the hotel and upcoming activities, billing information, room service, guest messages and wake-up services.
The system's architecture consists of a Network Operating Center (NOC) and local hotel servers connected through a point-to-point broadband network. As each guest accesses the network, the resulting traffic generated undergoes analysis based on various criteria. This includes behavioral, geographical, seasonality, and more. Using this data, hotels are able to ensure advertisers maximum value for their advertising budget. Disclaimer
TiVUS, Inc. Company Blog
TiVUS, Inc. News:
TiVUS Offers Free-to-Guest Hotel TV Digital Programming
TiVUS' Ad-Insertion Attracts Diverse Range of Advertisers
TiVUS' First Ad-Insertion Revenues Begin - Hotel TV advertising embraced by local merchants
Beacon Enterprise Solutions Group, Inc. (BEAC)
The QualityStocks Daily Newsletter would like to spotlight Beacon Enterprise Solutions Group, Inc. (BEAC). Today, Beacon Enterprise Solutions Group, Inc. closed trading at $0.22, even with yesterday's close, on 64,482 volume with 7 trades. The stock’s average daily volume over the past 60-days is 55,682 with a 52-week low/high of $0.14/$0.54.
Beacon Enterprise Solutions Group, Inc. (BEAC) specializes in designing, implementing and managing high performance Information Technology Systems ("ITS") infrastructure solutions. Offering national, multi-national and global, turnkey ITS infrastructure solutions, the company is capable of delivery professional services to Fortune 1000 and large multi-site firms as they increasingly single source and outsource to reduce costs while optimizing critical planning, design, program, project and construction management and managed services.
Leveraging standardization, rapid mobilization and a just-in-time professional services approach, Beacon Enterprise Solutions serves as a single source for national, multi-national and global enterprise clients, including special practices focused on data centers, campuses, smart buildings, outside plant, wireless systems and other technology-based applications and projects. Clients are provided with consistent and predictable results anywhere in the world. The company's solutions allow clients to focus on their core businesses without the distraction of having employees spend valuable time on services that Beacon can provide on any continent, in any country using any language.
Headquartered in Louisville, Kentucky, with regional headquarters in Cincinnati, Ohio, Dublin, Ireland, and Prague, Czech Republic, in addition to personnel located throughout the United States and Europe, Beacon Enterprise Solutions services a diverse range of clients. For more than 30 years, the company has enabled businesses in a variety of vertical markets to dramatically reduce costs, enable global standardization, manage day-to-day technology systems moves, adds and changes, and take on major projects – all under a single national, multi-national or global agreement.
Beacon Enterprise Solutions has carefully assembled a seasoned management team and operating strategy to maximize organic growth and new business development across multiple vertical markets. More than 4,000 companies, from small businesses to Fortune 50 firms, have chosen the company's solutions. Disclaimer
Beacon Enterprise Solutions Group, Inc. Blog
Beacon Enterprise Solutions Group, Inc. News:
Beacon Enterprise Solutions Highlights New Product Offering for Fortune 1000 Clients
Beacon Enterprise Solutions Reports 36% Increase in Blended Project Funnel
Beacon Enterprise Solutions Hires Industry Sales Veteran
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.008, even for the day, on 68,300 volume with 3 trades. The stock’s average daily volume over the past 60-day daily average volume is 296,351 with a 52-week low/high of $0.001/$0.0205.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings wholly-owned subsidiary Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
Consorteum Holdings Completes Acquisition of Tarsin Inc.
Consorteum Holdings, Inc. Announces Lead Spokesman for the First Nations MasterCard Program
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.73, even for the day, on 1,100 volume with 4 trades. The stock’s average daily volume over the past 60-day daily average volume is 1,926 with a 52-week low/high of $1.20/$1.75.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Announces Channel Sales Partnership With Primary Solutions
GlobalWise Provides Corporate Overview and History of Intellinetics
GlobalWise Introduces New Management Team
Today, Neuralstem, developers of a revolutionary platform of patented technologies for the production of neural stem cell lines and cell therapies, reported dosing of the fourteenth patient in its ongoing Phase I clinical trialing of the company’s spinal cord neural stem cells in ALS (amyotrophic lateral sclerosis or Lou Gehrig’s disease), marking the second patient to receive cells in the cervical (upper back) region of the spine and the trial’s first female patient. This is the first FDA-approved neural stem cell trial for the treatment of ALS.
This treatment is designed to help remediate breathing function loss associated with progressive ALS, and the transplantation of stem cells observed in the trial will be keenly watched for safety/efficacy of spinal cord neural stem cells, as well as the intraspinal transplantation method. The first twelve patients received lumbar (lower back) transplants and the trial has now been underway since January of 2010.
Having begun with non-ambulatory patients and progressing to patients able to walk, this trial has now entered into the final six patients, all of whom will receive cervical transplants, with trial conclusion projected for six months after the final surgery is complete. The proprietary CUR spinal cord delivery platform with floating cannula has helped tremendously in making this dream a possibility and represents a true breakthrough in the field, making the first ever intraspinal injections feasible.
Chairman and CSO of CUR, Karl Johe, PhD., was proud to be breaking new ground with this latest cohort of patients, as it represents a major milestone for the trial, with direct implantation of cells into the “gray matter of the spinal cord in the cervical region.” Dr. Johe was especially proud of the potential these successful surgeries represent for the numerous patients who suffer from significant quality of life impairment due to ALS. With the 14th successful transplant notched into their belts, CUR is confident that the demonstration of safety in this novel procedure is going quite well.
This is a huge coup for CUR which is also making significant advancements towards developing a robust cell therapy platform capable of addressing a wide range of major central nervous system conditions, ranging from spinal cord injuries and chronic stroke, to ischemic spastic paraplegia and other crippling conditions. The company has an IND submitted to FDA for Phase I safety trials in chronic spinal cord injury.
The company is also well-positioned to service systematic screening needs in the large chemical library space. With proprietary screening technology and the ability to generate appropriate human neural stem cell lines, CUR is ready to leverage discovered/patented compounds that help to stimulate brain activity and neuron regeneration. The potential exists to even reverse debilitating CNS conditions.
The company has also received FDA clearance to conduct a Phase Ib safety trial for their first small molecule compound, NSI-189, for treatment of MDD (major depressive disorder); technology that could easily pan out into schizophrenia, bipolar disorder, and Alzheimer’s offerings.
For more information on the trial, or on Neuralstem, Inc. please visit the company’s website at www.NeuralStem.com
eCrypt has built a robust security platform for military-grade strong encryption that the average consumer can use with ease, extending this envelope nicely with secured online file storage/sharing capability. The beauty of the technology is that it layers seamlessly with existing contact methodologies, allowing users to keep existing email accounts, meaning rapid deployment across an entire business is possible.
Entering the BlackBerry® space with the eCrypt One on One product for securing Mobile Mail Privacy (original app name), ECRY quickly moved towards a universal offering, eCrypt Me, a web-based implementation accessible by any intelligent networked device via the Web browser. Today the company continues to deliver on a pledge of making powerful encryption technology, once only available to banks, governments, and Fortune 500 companies, readily available to the consumer in a format that anyone can use.
Showing the prowess of the company’s developmental pipeline and their dedication to securing consumer space, ECRY launched the eCrypt Me app for the iPhone shortly after announcement of its development last year, bringing tighter usability to the already available platform via mobile browser.
Availability via the iTunes App Store places the product more prominently for consumers and is already generating significant buzz, as it constitutes a very simple yet powerful privacy/security solution and even allows users to circumvent the recently discovered messaging security flaw. Projections place the iPhone at some 18% of the entire smartphone market this year (some 116.4M units; over 50M sold in 2011 according to AAPL, currently 29% US market share – Michael Walkley, Cannacord Genuity) and the drive by the company to shell their technology into apps, avoiding the browser and allowing enhanced, device-specific functionality (as with the many features of the Blackberry One on One offering), speaks directly to the heart of those end users.
Let’s take a closer look at these offerings, examining eCrypt Me, eCrypt Me for iPhone, and even One on One to get a better sense of just how on target ECRY is with their technology design:
eCrypt Me – web-based encryption with secure cloud storage lets users safely and easily send off private emails to other users on or off platform, even via public WiFi via SSL, and uses a powerful combo of AES256/ECC521 algorithms to lock down data and passwords, giving end users total one-way encryption so strong not even ECRY can decrypt them. Easy to subscribe and easy to access, just login and use existing email accounts via any protocol like POP, IMAP, Groupwise, and etc. Works in every browser on any device, has a free 30-day trial, and only costs $8 per month, no contract required. Offers a very Gmail/Outlook-like organizational feature set and style that is immediately familiar to most users, and when paired with the File Vault lets users conduct business easily, even across continents, secure in the knowledge that everything is sealed away from prying eyes.
eCrypt Me for iPhone – leverages the entire framework in an iPhone-designed app environment, bringing the same easy to use, easy to navigate, complete end-to-end security framework for emails and attachments to the iPhone community.
eCrypt One on One – system-level device integration is where ECRY got its start and this offering is designed to shield email message contents on the BlackBerry, using the device-resident Messages and Contact/Address Book applications. Available via a single perpetual license per device for a one-time fee of $79.95. A free trial is also offered, making it easy to check out.
One in five cases of identity theft is initiated by email; it is really one of the most dangerous points of contact possible and is a leading target for the majority of malicious hackers and cyber criminals. A major obstacle for the millions of new users entering the market each year is the complexity, price, and availability of a truly robust strong encryption solution like this and it is quite natural for people, especially iPhone users who rely heavily on the iTunes store for apps, to flock to such products when they realize how prevalent identify theft is.
Intelligent consumers and businesses know that we all routinely handle sensitive data, and in the case of a business, it is especially important to safeguard such private information. Now there is a perfect option for anyone, irrespective of skill set, to implement this kind of ironclad security. If you can use email, you can use eCrypt.
For more information on eCrypt Technologies, Inc. please visit the company’s website at: www.eCryptInc.com
Enviro Voraxial Technology today announced it has received and shipped another multi-unit purchase order for its patented Voraxial® Separator, an in-line turbo-separator that separates large volumes of solids and liquids, from The South American National Oil Company, which will install the units on a FPSO (FPSO is short for Floating, Production, Storage and Offloading) for an offshore produced water application in South America.
Enviro previously shipped multiple Voraxial® Separators to this customer in 2011, and Enviro said it anticipates multiple repeat orders over the next several years.
“The customer is pleased with the performance of the Voraxial® and has decided to order additional units for its FPSO,” John A. DiBella, CEO of Enviro stated in the press release. “The Voraxial® offers the oil industry a cost effective method of processing and treating its wastewater, specifically in its ability to process large volume of liquids with less energy, less space and without any pressure loss.”
Enviro said the order reflects the commercial expansion of its Voraxial® Separator in international markets.
The company is experiencing increased inquiries for its line of Voraxial® Separators, especially for its larger models, the Voraxial® 4000 and Voraxial® 8000 Separators. Based on record sales in 2011 and increased inquiries for these separators, Enviro forecasts accelerated growth throughout 2012.
For more information visit www.evtn.com
Yesterday, Digerati Technologies announced that its direct inward dialing (DID) service is now available to customers in over 50 countries. The DID service allows Digerati to provide local telephone numbers to business customers with offices outside of the United States. In recent months, Digerati has experienced a growing demand for foreign telephone numbers and international calling from customers subscribing to the company’s cloud-based services.
Arthur L. Smith, CEO of Digerati stated, “Providing global DID services is a good example of how a seamless combination of our global network with our cloud-based applications increases the value-proposition of our product line. Businesses are looking for a one-stop-shop for cloud-based applications and global communication services, so it’s important that we continue to enhance our coverage to serve customers in every region of the world. We are also paying particular attention to countries expected to experience a spike in demand, such as Brazil that will be hosting the World Cup in 2014.”
In addition to cloud telephony applications, Digerati reported that its business customers are seeking solutions that allow for cost-effective communications on a global scale. Through its global partnerships, the company’s expanded DID coverage includes countries in North America, South America, Asia, Europe, and the Middle East.
Digerati is meeting the global needs of businesses that are seeking simple, flexible, and cost-effective communication solutions. Digerati’s cloud-based services include a fully-hosted IP/PBX, VoIP transport, SIP trunking, data storage, and customized VoIP solutions for specialized applications.
For more information, please visit the company website at www.digerati-inc.com
Today's Top 3
Bull in Advantage
The QualityStocks Public Company Sponsor News